Apatinib trials for Breast cancer

All Apatinib trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Apatinib for Breast cancer

• Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
  NCT06418594 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
  NCT06447623 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• SNF Platform Study of HR+/ HER2-advanced Breast Cancer
  NCT05594095 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
  NCT05447702 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Common questions

How many trials study Apatinib for Breast cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.